Balanced news tone
News Sentiment
MODD sentiment intelligence
Modular Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-13.3% over one week, -16.4% over four weeks, trend inactive, and below fair value.
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Modular Medical Receives Research Demonstrating Positive Payor Reception of Pivot Tubeless Patch Pump
Modular Medical, Inc. announced favorable findings from an independent market research study regarding its FDA-cleared Pivot™ tubeless patch pump. The research indicates positive reception from payors, recognizing the device's differentiated design, streamlined user experience, a
- Tone
- Positive 92/100
- Event
- Market update
- Published
- 15 Jul 2026 12:12
- Source
- Weatherford Democrat
A 300-IU Tubeless Pump Draws Favorable Payor Feedback
Modular Medical (NASDAQ: MODD) announced favorable results from an independent market research study concerning its FDA-cleared Pivot tubeless patch pump. The study indicated positive payor receptivity due to the pump's modular design, tubeless and reusable architecture, 300 IU r
- Tone
- Positive 70/100
- Event
- Earnings
- Published
- 15 Jul 2026 12:12
- Source
- Stock Titan
Modular Medical Announces Completion of Research Initiative Indicating Strong Interest in Simpler Insulin Delivery
Modular Medical, Inc. announced positive findings from a diabetic patient research initiative, indicating strong interest in simpler insulin pump therapy. The study showed that 97% of surveyed injection users would consider pump therapy if it were easier to learn and offered impr
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 14 Jul 2026 20:12
- Source
- New Castle News
Reflecting On Medical Devices & Supplies - Specialty Stocks’ Q1 Earnings: Integer Holdings (NYSE:ITGR)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 18:07
- Source
- Market source
Director at Modular Medical (MODD) receives stock and fully vested options grant
Modular Medical (MODD) director Steven G. Felsher received equity compensation, including 25 shares of common stock and an option to purchase 250 shares. The stock option was fully vested upon grant with an exercise price of $4.88 and an expiration date of June 30, 2036. These gr
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jul 2026 17:40
- Source
- Stock Titan
Director at Modular Medical (MODD) receives 250 fully vested options
Modular Medical, Inc. director Ellen O'Connor Vos was granted options to purchase 250 shares of common stock at an exercise price of $4.88 per share. These options, awarded under the Outside Director Compensation Plan, were fully vested and exercisable immediately on the grant da
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Director at Modular Medical (NASDAQ: MODD) receives option grant for 250 shares
Modular Medical (NASDAQ: MODD) director Jeff D. Goldberg was granted an option to purchase 250 shares of common stock. The option was awarded on June 30, 2026, under the company’s Outside Director Compensation Plan, at an exercise price of $4.88 per share, and was fully vested an
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 20:09
- Source
- Stock Titan
Director at Modular Medical (NASDAQ: MODD) awarded 110-share stock grant under plan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Director at Modular Medical (NASDAQ: MODD) awarded 83-share stock grant
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Modular Medical (MODD) director awarded fully vested options for 250 shares
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Jul 2026 07:00
- Source
- Stock Titan
Modular Medical Seeks FDA Clearance for Pivot Insulation Delivery System Enhancements
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 12:27
- Source
- MT Newswires
Modular Medical submits software enhancements for Pivot system to FDA
Modular Medical, Inc. (NASDAQ:MODD) has submitted software enhancements for its Pivot insulin delivery system to the FDA, which include customization options and user-interface improvements. This is the first of several planned upgrades after the system's initial FDA clearance. T
- Tone
- Positive 65/100
- Event
- Market update
- Published
- 01 Jul 2026 12:39
- Source
- Investing.com
Modular Medical seeks FDA sign-off for Pivot pump customization upgrades
Modular Medical (NASDAQ: MODD) has submitted software enhancements for its Pivot tubeless insulin patch pump to the FDA. These enhancements are the first in a planned series and include increased patient customization and UI improvements. The core Pivot form factor is already FDA
- Tone
- Positive 73/100
- Event
- Market update
- Published
- 01 Jul 2026 11:39
- Source
- Stock Titan
Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements
Modular Medical, Inc. announced the submission of software enhancements for its Pivot Tubeless Insulin Patch Pump to the FDA. These enhancements, focusing on patient flexibility, customization, and UI improvements, represent the first of several planned upgrades for the Pivot pla
- Tone
- Positive 72/100
- Event
- Market update
- Published
- 01 Jul 2026 11:39
- Source
- ACCESS Newswire
EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump
Modular Medical Inc. announced that the first patients are actively using its Pivot tubeless insulin patch pump, marking a significant step in the commercialization strategy for the device. The company will now gather real-world utilization data and user feedback to support broad
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 01 Jul 2026 08:31
- Source
- Market source
Director C. Frank Morgan receives stock options at Modular Medical (MODD)
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Modular Medical begins commercial insulin pump deployment
Modular Medical Inc. announced the commercial deployment of its Pivot tubeless insulin patch pump, with initial patients completing training and beginning use. This marks a transition to commercial-stage operation for the company, despite a negative free cash flow of $26.12 milli
- Tone
- Positive 65/100
- Event
- Balance sheet
- Published
- 01 Jul 2026 04:40
- Source
- Investing.com
Modular Medical Delivers Insulin to First Patients on Pivot Tubeless Insulin Patch Pump
Modular Medical, Inc. announced that the first patients are now actively using its Pivot™ tubeless insulin patch pump, marking a significant step in the company's commercialization strategy. This introduces the Pivot pump, designed for insulin-dependent adults relying on multiple
- Tone
- Positive 70/100
- Event
- Market update
- Published
- 30 Jun 2026 17:09
- Source
- Voice of Alexandria
First patients are using Modular Medical’s Pivot patch pump
Modular Medical (NASDAQ: MODD) announced that the first patients have started using its Pivot tubeless insulin patch pump, marking a key transition from development to active patient use. This development is part of the company's commercialization strategy to target the multibill
- Tone
- Positive 81/100
- Event
- Analyst action
- Published
- 30 Jun 2026 13:09
- Source
- Stock Titan
Modular Medical FY 2026: Net loss $28.2M, EPS $(12.36) — 10-K Summary
Modular Medical, Inc. (MODD) reported a significant widening of its net loss for fiscal year 2026, reaching $28.2 million compared to $18.8 million in 2025, with EPS of $(12.36). This increase in losses is attributed to higher R&D and G&A expenses, despite recent FDA clearances f
- Tone
- Negative 14/100
- Event
- Earnings
- Published
- 29 Jun 2026 21:40
- Source
- TradingView
[10-K] Modular Medical, Inc. Files Annual Report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
Modular Medical ships Pivot insulin pump kits
Modular Medical (NASDAQ:MODD) has begun shipping its Pivot tubeless insulin patch pump starter kits to endocrinology practices for physician training. This phased rollout targets adult patients on multiple daily insulin injections, representing about 70% of insulin-dependent adul
- Tone
- Positive 81/100
- Event
- Market update
- Published
- 26 Jun 2026 17:09
- Source
- grafa.com
Modular Medical Inc Actuals & Estimates (NASDAQ:MODD)
The article provides a detailed overview of Modular Medical, Inc. (NASDAQ: MODD) stock, including its current price, historical performance, volatility, and market capitalization. It also covers financial actuals and estimates, employee count, and dividend policy, concluding with
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 26 Jun 2026 13:10
- Source
- TradingView
Modular Medical begins shipping Pivot insulin pump to doctors
Modular Medical (NASDAQ: MODD) has started shipping its Pivot tubeless insulin patch pump to physician offices for training, with plans to introduce it to patients soon. Despite facing financial challenges, including a significant drop in stock value and burning through cash, the
- Tone
- Positive 64/100
- Event
- Balance sheet
- Published
- 26 Jun 2026 12:09
- Source
- Investing.com
Modular Medical Announces Shipment of Pivot Tubeless Patch Pumps
Modular Medical, Inc. has announced that its Pivot tubeless insulin patch pump is now shipping to endocrinology practices for physician training. This marks a significant milestone in the deployment of the Pivot system, designed for adults with diabetes currently on multiple dail
- Tone
- Positive 76/100
- Event
- Market update
- Published
- 26 Jun 2026 12:09
- Source
- Corsicana Daily Sun
Modular Medical starts shipping Pivot pumps to doctors' offices
Modular Medical (NASDAQ: MODD) has announced that its Pivot tubeless insulin patch pump starter kits are now being shipped to endocrinology practices for physician training. This marks a significant step towards commercialization, with pumps expected to be offered to patients in
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 26 Jun 2026 12:09
- Source
- Stock Titan
Modular Medical Inc Actuals & Estimates (BOATS:MODD)
This article provides financial actuals and estimates for Modular Medical, Inc. (MODD) traded on the BOATS exchange. It covers income statement, balance sheet, cash flow, and valuation metrics, along with FAQs about its stock ticker, historical prices, financial reports, net inco
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 26 Jun 2026 07:09
- Source
- TradingView
EXCLUSIVE: Modular Medical Transitions To Commercial Stage With Pivot Insulin Pump Launch
Modular Medical (NASDAQ: MODD) has made its Pivot tubeless insulin patch pump commercially available in the U.S., marking its transition to a commercial-stage medical device company. Pivot is designed to simplify insulin delivery for adults with diabetes who currently use multipl
- Tone
- Positive 75/100
- Event
- Market update
- Published
- 26 Jun 2026 02:09
- Source
- Sahm
Modular Medical launches Pivot insulin patch pump in U.S.
Modular Medical (NASDAQ:MODD) has launched its Pivot tubeless insulin patch pump commercially in the United States, with initial shipments starting this week. The device, which received FDA 510(k) clearance in April 2026, is the second fully electronic, tubeless insulin pump avai
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 25 Jun 2026 13:10
- Source
- Investing.com
Spotting Winners: Merit Medical Systems (NASDAQ:MMSI) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q1
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Jun 2026 07:00
- Source
- Market source